HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CYP24A1 is an independent prognostic marker of survival in patients with lung adenocarcinoma.

AbstractPURPOSE:
The active form of vitamin D, 1α,25-dihydroxyvitamin D(3) (1,25-D(3)), exerts antiproliferative effects in cancers, including lung adenocarcinoma (AC). CYP24A1 is overexpressed in many cancers and encodes the enzyme that catabolizes 1,25-D(3). The purpose of our study was to assess CYP24A1 as a prognostic marker and to study its relevance to antiproliferative activity of 1,25-D(3) in lung AC cells.
EXPERIMENTAL DESIGN:
Tumors and corresponding normal specimens from 86 patients with lung AC (stages I-III) were available. Affymetrix array data and subsequent confirmation by quantitative real time-PCR were used to determine CYP24A1 mRNA expression. A subsequent validation set of 101 lung AC was used to confirm CYP24A1 mRNA expression and its associations with clinical variables. The antiproliferative effects of 1,25-D(3) were examined using lung cancer cell lines with high as well as low expression of CYP24A1 mRNA.
RESULTS:
CYP24A1 mRNA was elevated 8- to 50-fold in lung AC (compared to normal nonneoplastic lung) and significantly higher in poorly differentiated cancers. At 5 years of follow-up, the probability of survival was 42% (high CYP24A1, n = 29) versus 81% (low CYP24A1, n = 57) (P = 0.007). The validation set of 101 tumors showed that CYP24A1 was independently prognostic of survival (multivariate Cox model adjusted for age, gender, and stage, P = 0.001). A549 cells (high CYP24A1) were more resistant to antiproliferative effects of 1,25-D(3) compared with SKLU-1 cells (low CYP24A1).
CONCLUSIONS:
CYP24A1 overexpression is associated with poorer survival in lung AC. This may relate to abrogation of antiproliferative effects of 1,25-D(3) in high CYP24A1 expressing lung AC.
AuthorsGuoan Chen, So Hee Kim, Amanda N King, Lili Zhao, Robert U Simpson, Paul J Christensen, Zhuwen Wang, Dafydd G Thomas, Thomas J Giordano, Lin Lin, Dean E Brenner, David G Beer, Nithya Ramnath
JournalClinical cancer research : an official journal of the American Association for Cancer Research (Clin Cancer Res) Vol. 17 Issue 4 Pg. 817-26 (Feb 15 2011) ISSN: 1557-3265 [Electronic] United States
PMID21169243 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Copyright©2010 AACR.
Chemical References
  • Cytostatic Agents
  • RNA, Messenger
  • Receptors, Calcitriol
  • Steroid Hydroxylases
  • CYP24A1 protein, human
  • Vitamin D3 24-Hydroxylase
  • Calcitriol
Topics
  • Adenocarcinoma (genetics, mortality, pathology)
  • Calcitriol (pharmacology)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Cytostatic Agents (pharmacology)
  • Genetic Association Studies
  • Humans
  • Kaplan-Meier Estimate
  • Lung Neoplasms (genetics, mortality, pathology)
  • RNA, Messenger (metabolism)
  • Receptors, Calcitriol (genetics, metabolism)
  • Steroid Hydroxylases (genetics, metabolism)
  • Up-Regulation
  • Vitamin D3 24-Hydroxylase

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: